Related Experiment Video
Updated: May 1, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Rapid C-reactive protein and white cell tests decrease cost and shorten emergency visits
Eeva Kokko1, Matti Korppi, Merja Helminen
1Tampere Centre for Child Health Research, Tampere University and University Hospital, Tampere, Finland.
Insights
Rapid testing for white blood cells (WBC) and C-reactive protein (CRP) in children significantly reduces emergency room (ER) stays and costs. This approach is effective when no further examinations or emergency treatments are required.
Area of Science:
- Pediatric Emergency Medicine
- Clinical Pathology
- Health Economics
Background:
- Elevated white blood cells (WBC) and C-reactive protein (CRP) are common, non-specific indicators of bacterial infection in children.
- Current diagnostic methods can lead to prolonged patient stays and increased healthcare expenses.
Purpose of the Study:
- To evaluate the impact of rapid WBC and CRP testing on patient flow within pediatric emergency rooms (ERs).
- To assess the cost-effectiveness of rapid WBC and CRP testing compared to traditional laboratory methods.
Main Methods:
- Retrospective chart review of 166 children treated in a pediatric ER over 3 months.
- Analysis of the association between rapid WBC/CRP testing and emergency department length of stay.
- Comparison of rapid test costs versus standard hospital laboratory costs.
Main Results:
- Median ER stay was significantly shorter with rapid testing (142.5-147.5 min) compared to laboratory tests or emergency treatment (179.5-201.5 min).
- Rapid testing costs were only 41.5% of the equivalent laboratory testing costs.
- These benefits were most pronounced in children discharged without further examinations or emergency interventions.
Conclusions:
- Simultaneous rapid testing for CRP and WBC effectively decreases costs and shortens ER stays for children with suspected infections.
- Rapid testing offers a cost-saving alternative, costing less than half of traditional laboratory analysis.
- Implementation of rapid testing can optimize patient flow and resource allocation in pediatric ER settings.
Background:
Elevated white blood cells (WBC) in blood and C-reactive protein (CRP) in serum are often used as non-specific markers for bacterial etiology of infection in children. The aim of the present study was to evaluate how rapid WBC and CRP testing influences patient flow and cost in the pediatric emergency room (ER).
Methods:
This study was a retrospective chart review. In all, 166 children who were treated during 3 months in the ER of a children's hospital, and in whom rapid tests for WBC and CRP were done, were included. The association between rapid testing and length of ER stay was evaluated, and the cost of rapid tests was compared with the corresponding cost if done in the hospital laboratory.
Results:
Median ER stay was 147.5 min, if no examinations other than rapid CRP and WBC tests were done and if no emergency treatment was given, compared with 201.5 min for laboratory tests or emergency treatment given (P < 0.001). The respective figures were 142.5 min and 179.5 min in those 96 children discharged home (P = 0.003). The cost of rapid testing was only 41.5% of the corresponding laboratory cost.
Conclusion:
The simultaneous rapid testing of CRP and WBC in children with presumable infection decreased cost and shortened the length of ER stay, if no other examinations or emergency treatment were needed. The cost of rapid testing was less than half of the corresponding cost in laboratory.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
Pneumonia III: Complications and Assessment
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Inflammation II: Local and Systemic Effects

